|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.62 USD | +1.02% |
|
+1.53% | +20.10% |
| 08-06 | Wedbush Adjusts Price Target on Arcus Biosciences to $43 From $41, Maintains Outperform Rating | MT |
| 08-05 | Arcus Biosciences, Inc., Q2 2026 Earnings Call, Aug 05, 2026 |
Transcripts
Search
No results match your criteria
Select your edition
All financial news and data tailored to specific country editions
















